Navigation Links
Scientists: New technique identifies molecular 'biomarkers' for disease
Date:3/31/2008

GAINESVILLE, Fla. --- University of Florida chemists are the first to use a new tool to identify the molecular signatures of serious diseases -- without any previous knowledge of what these microscopic signatures or biomarkers should look like.

Reported this month in the online edition of the Journal of Proteome Research, the advance could one day lead to earlier detection and improved treatment of some types of cancer as well as other diseases.

With many diseases, the problem has been that we really dont know what to look for, said Weihong Tan, a professor of chemistry and the lead author of the paper. What weve done is create a technique to identify the biomarkers despite that limitation.

Doctors often diagnose cancer and other diseases based on the appearance of a tumor or a patients symptoms. While such traditional methods can be effective, they sometimes identify a disease only after it is established. For example, clinicians may get tipped off to the presence of lung cancer which kills more people than any other type of cancer based on visible images of a tumor that appear on radiological exams of a patients lungs.

Because earlier detection typically improves outcomes, doctors would like to spot disease at the molecular level, before it grows or spreads and manifests itself in more obvious and harmful ways. Given that diseased cells molecular structures differ from those of healthy ones, that approach should be possible, and researchers have had some success finding such biomarkers using antibodies, Tan said. But despite years of research, biomarkers for most diseases remain elusive or unreliable, he said.

His group turned to aptamers, single-strand chains of DNA or RNA that recognize and bind to target protein molecules, as a new tool. His paper reports the first-ever successful use of the aptamers to discover a molecular biomarker in this case, one for leukemia.

Tan said his group used cell-SELEX, a process his group developed and patented.

Researchers create trillions of different varieties of aptamers in a solution. They then immerse cells known to carry the sought-after disease in the solution. After an incubation period, they rinse the cells.

The vast majority of the aptamers wash away, but those with stronger molecular affinity for the diseased cells remain. The researchers repeat the process several times, eventually shrinking the pool of aptamers to as few as 10 to 25 very strongly attached aptamers those most closely associated with the diseased cells. Analysis then reveals these aptamers molecular structure, as well as the molecular structure of the cells biomarkers they bind to.

As long as the molecules in question are expressed in a substantially different way on diseased and normal cells, they can be identified, Tan said.

Rebecca Sutphen, associate professor and director of the Genetic Counseling & Testing Service at the H. Lee Moffitt Cancer Center & Research Institute in Tampa, said improved diagnosis may not be the only application of the research.

The opportunity to identify cancer cell-specific biomarkers and potentially detect small numbers of cancer cells has many potential clinical applications, including disease detection, better imaging of tumors and even potential application for stem cells, she said.

Other biomarkers have been found for leukemia, but none is particularly reliable, Tan said. Tan and his colleagues reported using aptamers to recognize cancer cells in a 2006 paper in the Proceedings of the National Academy of Sciences. Tan said the latest paper advances that work by revealing the target biomarkers the selected aptamers recognize, Tan said. These targets will form a molecular foundation in understanding diseases, he said.

In 2006, we did not know what the aptamer recognized on the cancer cell surface, he said. In this current work, we report discovering these biomarkers, which then form the molecular foundation for us to understand the cancer and to prepare different molecular tools for molecular medicine.

Tan said the research is particularly promising because aptamers are relatively easy and inexpensive to manufacture compared with antibodies. This offers the potential for wider application, he said, adding that aptamers could one day be used not only to detect disease, but also to ferry therapeutic agents to diseased cells.


'/>"/>

Contact: Weihong Tan
tan@chem.ufl.edu
352-846-2410
University of Florida
Source:Eurekalert

Related medicine news :

1. Eye-staining technique offers early detection for dry eye syndrome
2. New technique detects specific chromosomal damage, may indicate lung cancer risk
3. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
4. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
5. Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery
6. Radiation therapy technique reduces length of prostate cancer treatment
7. Radiation therapy technique reduces length of prostate cancer treatment
8. IVF technique enables pregnancy without multiple births, Stanford researchers find
9. UT Southwestern investigating hypothermic technique in treating pediatric head injuries
10. UCLA doctor develops new technique to treat varicose veins
11. New technique improves purity of medicines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Segundo, CA (PRWEB) , ... March 23, 2017 ... ... Verisys FACIS Monthly Monitoring Healthcare products at competitive pricing. Verisys ... source sanctions, Exclusions, Debarments, License restrictions and Disciplinary actions. , “We are delighted ...
(Date:3/23/2017)... Jersey (PRWEB) , ... March 23, 2017 , ... ... of herbal-based and non-steroidal skincare products, was awarded as winners of American Dreams ... products. This competition was hosted jointly by HSN and Good Housekeeping. , ...
(Date:3/23/2017)... ... March 23, 2017 , ... The Boulevard is honored ... 2pm. All events will be located in the Main West Entrance of The ... Child ID event. No appointment is necessary and each child with a parent or ...
(Date:3/23/2017)... , ... March 23, 2017 , ... “Beyond and Back”: ... and Back” is the creation of published author Bonetta Rose, a wife, mother and ... lives. , Published by Christian Faith Publishing, Bonetta Rose‘s new book presents actual events ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... selected HealthiPASS, an innovative patient - centric payment system, to expand its focus ... improvements in the patient financial experience. , “At Ogden Clinic, we are ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... DUBLIN , Mar 22, 2017 Research ... Packaging Market Analysis & Trends - Industry Forecast to 2025" ... ... at a CAGR of around 7.1% over the next decade to ... analyzes the market estimates and forecasts for all the given segments ...
(Date:3/22/2017)... 22, 2017  Applied BioMath ( www.appliedbiomath.com ), ... research and development, today announced the latest line-up ... 2017 is a day full of presentations, posters, ... (QSP) community. The focus is to learn about ... accelerating drug research and development. The ...
(Date:3/22/2017)... Massachusetts , March 22, 2017 ... solutions, announced today that Newton-Wellesley Hospital, a nationally recognized medical ... significant improvement in patient outcomes following continued implementation of its ... overall reduction of 59% in median nurse response time to ... ...
Breaking Medicine Technology: